Transforming growth factor (TGF)-β expression and activation mechanisms as potential targets for anti-tumor therapy and tumor imaging

Pharmacology & Therapeutics
Marlous ArjaansCarolina P Schröder

Abstract

Cancer remains one of the leading causes of death in the developed countries and cancer mortality is expected to rise globally. Despite encouraging developments regarding targeted drugs, the most prevalent cancer mortality remains metastatic disease. Therefore, drugs that target cancer progression, invasion and metastasis are clearly needed. One of the most interesting targets in this setting is transforming growth factor β (TGF-β). TGF-β can promote tumor growth, invasion and metastasis. However, TGF-β also has a physiological, opposing role: maintaining tissue homeostasis and suppression of tumor progression. The window of effective TGF-β targeting is therefore evidently small, which poses a clear challenge in selecting patients at the right time. Despite this complexity, several TGF-β inhibitors are currently in clinical development, modulating TGF-β production, activation or signaling. Still, specificity and long term toxicity remain unclear, emphasizing the importance of careful monitoring of clinical trials. Development and application of these drugs in the clinic require adequate insight and evaluation methods for the role of TGF-β during tumor invasion and metastasis. In this review, presently available methods for clin...Continue Reading

References

Oct 1, 1992·Molecular Biology of the Cell·R Flaumenhaft, D B Rifkin
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D R WelchM Nakajima
Feb 1, 1994·The Journal of Clinical Investigation·M H Barcellos-HoffJ A Weatherbee
Oct 1, 1993·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J M BreussR Pytela
Dec 28, 1999·Microbes and Infection·N Khalil
Dec 17, 2002·Journal of Cell Science·Justin P AnnesDaniel B Rifkin
Jun 18, 2003·Cell·Yigong Shi, Joan Massagué
Jun 9, 2004·The Journal of Cell Biology·Justin P AnnesDaniel B Rifkin
Aug 18, 2005·Journal of Cell Science·Aristidis Moustakas, Carl-Henrik Heldin
Nov 29, 2005·Cytokine & Growth Factor Reviews·Laurence Levy, Caroline S Hill
Mar 2, 2006·Current Oncology Reports·Gordon C Tucker
Apr 20, 2006·Biochemical Pharmacology·Jan Pinkas, Beverly A Teicher
Jun 24, 2006·Nature Reviews. Cancer·Brian Bierie, Harold L Moses
Jul 22, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rongrong GeMichael Reiss
Sep 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John NemunaitisHabib Fakhrai
Nov 15, 2006·Current Cancer Drug Targets·Elise F Saunier, Rosemary J Akhurst
Apr 25, 2007·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·D L FarringtonC A Ray
Jun 5, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christine DesmedtUNKNOWN TRANSBIG Consortium
Jul 17, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Wouter B NagengastMarjolijn N Lub-de Hooge
Oct 2, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Lujun ZhaoFeng Ming Kong
Dec 19, 2007·The Journal of Cell Biology·Pierre-Jean WipffBoris Hinz
Feb 14, 2008·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Jose BaselgaMichael Carducci
Mar 18, 2008·European Journal of Cell Biology·Pierre-Jean Wipff, Boris Hinz
Jul 30, 2008·Cell·Joan Massagué
Aug 21, 2008·International Journal of Cancer. Journal International Du Cancer·Sabine RiethdorfKlaus Pantel
Oct 9, 2008·Breast Cancer Research and Treatment·Antoinette R TanMichael Reiss
Dec 26, 2008·The New England Journal of Medicine·Anne C Chiang, Joan Massagué
Jul 16, 2009·Current Drug Targets·A Bandyopadhyay, S Raghavan
Apr 17, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Wouter B NagengastElisabeth G E de Vries
May 5, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roger StuppMichael Weller
Sep 28, 2010·Trends in Biochemical Sciences·John J WorthingtonMark A Travis

❮ Previous
Next ❯

Citations

Nov 28, 2012·Archives of Gynecology and Obstetrics·Hugo López-MuñozLuis Sánchez-Sánchez
Jun 4, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Sheila C AraujoKathia M Honorio
Feb 26, 2013·European Journal of Internal Medicine·Hadi A GoubranMagdy El-Ekiaby
Nov 26, 2015·International Journal of Pharmaceutics·Zahra KakhiBéatrice Heurtault
Nov 3, 2015·Journal of Biomolecular Structure & Dynamics·Michell O AlmeidaKathia M Honorio
Apr 23, 2013·International Journal of Urology : Official Journal of the Japanese Urological Association·Daisuke YamadaYukio Homma
Apr 25, 2018·Journal of Cell Science·Irina RaykhelJohanna Myllyharju
Nov 15, 2017·Journal of Biomolecular Structure & Dynamics·Michell O AlmeidaKathia M Honorio
May 30, 2019·Journal of Cellular Physiology·Feng TangBing Zhao
Mar 5, 2013·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Naoyuki KawaoHiroshi Kaji
Oct 23, 2019·Molecular Biology Reports·Hongliang WangBing Zhao
Jan 29, 2021·PloS One·Gabriel Z EspinozaKathia M Honorio
Mar 30, 2021·Cancer Biomarkers : Section a of Disease Markers·Miral Magdy ShehataHala Osman El-Mesallamy
Jul 3, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Martha W den HollanderAnnemiek M E Walenkamp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.